In the context of small cell lung cancer (SCLC), Wei et al. conducted a study identifying five potential mRNA vaccine neoantigens, namely, NEK2, NOL4, RALYL, SH3GL2, and ZIC2. This evidence concerns the gene RALYL and small cell lung carcinoma.